Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

APOTEX

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 17
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

MYLAN

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 17
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

SIGMAPHARM LABS LLC

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 11
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 26
  • 0 comments

FDA approve TORSEMIDE

Comment Full text

TEVA PHARMS USA INC

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 21
  • 0 comments

FDA approve LAPATINIB DITOSYLATE

Comment Full text

GILEAD

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 17
  • 0 comments

FDA approve AMBRISENTAN

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 19
  • 0 comments

FDA approve DABIGATRAN ETEXILATE MESYLATE

Comment Full text

MYLAN

  • FDA Approval
  • Aug. 20, 2024, 08:55 UTC
  • 28
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM; NAPROXEN

Comment Full text

PHARMACIA

  • FDA Approval
  • Aug. 19, 2024, 08:49 UTC
  • 17
  • 0 comments

FDA approve SOMATROPIN

Comment Full text

HIKMA

  • FDA Approval
  • Aug. 19, 2024, 08:49 UTC
  • 21
  • 0 comments

FDA approve ROPIVACAINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 281
  • 282
  • 283
  • 284
  • 285
  • Next

Search

News categories

  • Technical Exchange News(9979)
  • Event(412)
  • SEC News(169143)
  • FDA Approval(9386)
  • Company Report(721)
  • Business News(112728)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin